Bitcoin halving
What does that mean?
$2.44T
Total marketcap
$116.75B
Total volume
BTC 51.61%     ETH 15.03%
Dominance

Novo Nordisk A/S NNOR.VI Stock

184.42 EUR {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Austria
Exchange
Vienna
Market Cap
413.31B EUR
LOW - HIGH [24H]
0.0000 - 0.0000 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR

Novo Nordisk A/S Price Chart

Novo Nordisk A/S NNOR.VI Financial and Trading Overview

Novo Nordisk A/S stock price 184.42 EUR
Previous Close 184.42 EUR
Open 187.3 EUR
Bid 0 EUR x 0
Ask 0 EUR x 0
Day's Range 46.11 - 187.3 EUR
52 Week Range 46.11 - 187.3 EUR
Volume 34 EUR
Avg. Volume 337 EUR
Market Cap 413.31B EUR
Beta (5Y Monthly) 0.242117
PE Ratio (TTM) 46.22055
EPS (TTM) 0 EUR
Forward Dividend & Yield 1.9 (1.04%)
Ex-Dividend Date August 18, 2023
1y Target Est N/A

NNOR.VI Valuation Measures

Enterprise Value 400.39B EUR
Trailing P/E 46.22055
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.052936
Price/Book (mrq) 4.568244
Enterprise Value/Revenue 1.989
Enterprise Value/EBITDA 4.31

Trading Information

Novo Nordisk A/S Stock Price History

Beta (5Y Monthly) 0.242117
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 187.3 EUR
52 Week Low 46.11 EUR
50-Day Moving Average 85.53 EUR
200-Day Moving Average 74.44 EUR

NNOR.VI Share Statistics

Avg. Volume (3 month) 337 EUR
Avg. Daily Volume (10-Days) 601 EUR
Shares Outstanding 1.7B
Float 1.61B
Short Ratio N/A
% Held by Insiders 5.97%
% Held by Institutions 41.95%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 14.15
Trailing Annual Dividend Yield 7.67%
5 Year Average Dividend Yield 181.00%
Payout Ratio 0.4165
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) June 30, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 33.39%
Operating Margin (ttm) 43.20%
Gross Margin 84.35%
EBITDA Margin 46.14%

Management Effectiveness

Return on Assets (ttm) 21.75%
Return on Equity (ttm) 81.53%

Income Statement

Revenue (ttm) 201.33B EUR
Revenue Per Share (ttm) 89.38 EUR
Quarterly Revenue Growth (yoy) 31.60%
Gross Profit (ttm) 148.51B EUR
EBITDA 92.89B EUR
Net Income Avi to Common (ttm) 67.24B EUR
Diluted EPS (ttm) 3.99
Quarterly Earnings Growth (yoy) 45.89%

Balance Sheet

Total Cash (mrq) 36.41B EUR
Total Cash Per Share (mrq) 16.22 EUR
Total Debt (mrq) 25.7B EUR
Total Debt/Equity (mrq) 28.41 EUR
Current Ratio (mrq) 0.878
Book Value Per Share (mrq) 40.37

Cash Flow Statement

Operating Cash Flow (ttm) 89.73B EUR
Levered Free Cash Flow (ttm) 53.32B EUR

Profile of Novo Nordisk A/S

Country Austria
State N/A
City Bagsvaerd
Address Novo Alle 1
ZIP 2880
Phone 45 44 44 88 88
Website https://www.novonordisk.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 59337

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Q&A For Novo Nordisk A/S Stock

What is a current NNOR.VI stock price?

Novo Nordisk A/S NNOR.VI stock price today per share is 184.42 EUR.

How to purchase Novo Nordisk A/S stock?

You can buy NNOR.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Novo Nordisk A/S?

The stock symbol or ticker of Novo Nordisk A/S is NNOR.VI.

Which industry does the Novo Nordisk A/S company belong to?

The Novo Nordisk A/S industry is Biotechnology.

How many shares does Novo Nordisk A/S have in circulation?

The max supply of Novo Nordisk A/S shares is 2.24B.

What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?

Novo Nordisk A/S PE Ratio is 0.00000000 now.

What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?

Novo Nordisk A/S EPS is 0 EUR over the trailing 12 months.

Which sector does the Novo Nordisk A/S company belong to?

The Novo Nordisk A/S sector is Healthcare.